Nektar Receives Patent Covering Pulmonary Targeted
Antibiotics.
Nektar Therapeutics (San Carlos, CA) announced that the United
States Patent and Trademark Office issued United States Patent
7,368,102, which covers compositions and methods for creating . . .
Neuralstem Responds to New StemCells Lawsuit.
Stem cell company Neuralstem, Inc. (Rockville, MD) responded to two
new patent infringement suits filed against it by StemCells, Inc., (Palo
Alto, CA) saying that it believes them, and the earlier . . .
Intellect Neurosciences Grants License for Certain Patents and
Patent Applications to Wyeth and Elan Pharma International.
Intellect Neurosciences, Inc. (New York, NY), a biopharmaceutical
company focused on development of disease-modifying therapeutic agents
for the treatment and prevention of Alzheimer's disease . . .
Oncolytics Announces Issuance of 27th U.S. Patent.
Oncolytics Biotech, Inc. (Calgary, Canada) has been granted United
States Patent 7,374,752 entitled "Reovirus for the Treatment of
Cellular Proliferative Disorders." The claims cover . . .
Applied Research Systems obtains United States patent.
Applied Research Systems ARS Holding N.V. (Curacao, Netherlands)
has patented a method for improving homogeneity and/or secretion of a
recombinant protein of interest expressed in mammalian cells . . .
Japan Patent Office Licenses GeneCards from Xennex.
Xennex, Inc. (Cambridge, MA) announced that the Japan Patent Office
(JPO) has licensed GeneCards(R). Xennex also announced that it has
selected Bioscene Informatics, Inc. (Bioscene) as its . . .
Jury Validates Key Mannatech Technology Patents Involving Its
Ambrotose Glyconutrient Products.
Mannatech, Incorporated (Coppell, TX), a leading developer and
provider of dietary supplements and skin care solutions, announced that
a federal court jury in the Northern District of Texas found . . .
District Court Decision Affirmed in U.S. Lovenox Patent
Infringement Case.
Sanofi-Aventis (Paris, France) announced that the United States
Court of Appeals for the Federal Circuit has affirmed the February 8,
2007 decision by the United States District Court for the . . .
Centia Advanced Biofuels Process Awarded Development Grant from
Biofuels Center of North Carolina.
Centia, an advanced biofuels conversion technology being developed
by North Carolina State University, has been awarded a $200k development
grant from the Biofuels Center of North Carolina. The . . .
ChemoCentryx obtains United States patent.
ChemoCentryx, Inc. (Mountain View, CA) has patented a modified cell
migration assay allowing for improved identification and discrimination
of chemokine receptor antagonists from non-specific . . .
SomaLogic and Otsuka Enter Into Research Collaboration Focusing
On Diagnostic Products and Target Validation.
SomaLogic, Inc. (Boulder, CO) announced that SomaLogic and Otsuka
Pharmaceutical Co., Ltd. entered into a collaboration agreement to use
SomaLogic's proprietary aptamer technology to discover and . . .
Landmark Alzheimer's Report Urges Radical Changes to
Paradigm of Therapy Development.
The development of therapies that could prevent Alzheimer's
disease, dementia and other memory disorders calls for increased focus
on early detection before symptoms emerge, significant changes . . .
Biopure Wins European Patent Challenge.
Biopure Corporation (Cambridge, MA) has successfully defended a
challenge at the European Patent Office to its European Patent entitled,
"A Method for Chromatographic Removal of Prions." . . .
Novozymes obtains United States patent.
Novozymes A/S (Bagsvaerd, Denmark) has patented lipolytic enzymes
which are chemically modified by covalently linking one or more
(particularly 1-3) hydrophobic groups to the enzyme molecule. . . .
GliaMed obtains United States patent.
GliaMed, Inc. (New York, NY) has patented neurotrophic
N-glyoxyl-prolyl ester compounds having an affinity for FKBP-type
immunophilins, their preparation and use as inhibitors of the . . .
Boston Scientific Announces Dismissal of Johnson & Johnson
Patent Lawsuit in Canada.
Boston Scientific Corporation (Natick, MA) announced that the
Canadian Federal Court has issued judgment in a lawsuit in which Johnson
& Johnson had accused the Company's NIR stent of infringing . . .
bioMETRX Applies for Several New Patents.
bioMETRX, Inc. (Jericho, NY) a leading developer of biometric based
consumer products, has filed 5 new patent applications with the United
States Patent and Trademark Office.
The products covered . . .
Lotus Pharmaceuticals Obtains Patent and Exclusive Production
Rights to Laevo-Bambutero Asthma Treatment.
Lotus Pharmaceuticals, Inc. (Beijing, China), a pharmaceutical
company in the People's Republic of China, has signed the
technology transfer agreement for Laevo- Bambutero with Dongguan . . .
StemCyte Expands Support of World Renowned Spinal Cord Injury
Researcher Through Agreement with Rutgers.
StemCyte, Inc. (Arcadia, CA) and Rutgers University (Piscataway,
NJ) have entered into a research and licensing agreement for a spinal
cord injury therapy being developed by Wise Young, M.D., . . .
Amgen obtains United States patent.
Amgen, Inc. (Thousand Oaks, CA) has patented DNA sequences coding
for a TNF-binding protein and for the TNF receptor of which this protein
constitutes the soluble domain. The DNA sequences can be . . .
|
|